Cannabis Tax Structures in Switzerland

The three regulatory buckets

Swiss cannabis tax rules depend entirely on which legal bucket a product falls into. There is no unified 'cannabis tax code.'

1. Low-THC CBD products (below 1.0% THC) fall outside the Narcotics Act (Betäubungsmittelgesetz, BetmG, SR 812.121) ^[1]. They are legal to sell but are taxed under the federal Tobacco Tax Act (Tabaksteuergesetz, TStG, SR 641.31) when marketed for smoking or as a tobacco substitute ^[2].

1. Medical cannabis has been available by ordinary prescription since 1 August 2022, after Parliament amended the BetmG to remove the previous exceptional-authorization requirement from the Federal Office of Public Health (FOPH/BAG) ^[3]. It is dispensed through pharmacies and taxed like other medicines.

1. Adult-use (recreational) cannabis remains prohibited under BetmG Art. 8, except within scientific pilot trials authorized by BetmG Art. 8a and the associated Ordinance on Pilot Trials (BetmPV, SR 812.121.5) that came into force on 15 May 2021 ^[4]. These trials (Zurich, Basel, Bern, Lausanne, and others) sell cannabis at controlled prices to registered participants.

How CBD is taxed: the tobacco-substitute rule

The Swiss Federal Customs Administration (now the Federal Office for Customs and Border Security, BAZG) issued guidance clarifying that CBD hemp products sold as smokable flower, pre-rolls, or vape substitutes are 'tobacco substitutes' (Ersatzprodukte) under Art. 1 para. 2 TStG ^[2][5].

The applicable rate for tobacco substitutes is 25% of the retail selling price (Art. 10 TStG in conjunction with the Tobacco Tax Ordinance) ^[2]. Importers and Swiss manufacturers must register with BAZG and pre-pay the tax; retail-facing prices already include it.

On top of that, standard VAT of 8.1% applies (raised from 7.7% on 1 January 2024) ^[6]. CBD oils marketed as cosmetics or food supplements are not tobacco substitutes and only carry VAT — though food-supplement claims trigger separate food-safety regulation under the FSVO/BLV, which most CBD oils cannot currently satisfy Strong evidence.

The folklore that 'CBD isn't really taxed in Switzerland because it's a wellness product' is wrong Disputed. Smokable CBD hemp has carried the 25% tobacco-substitute levy since a 2019 clarification, and BAZG has pursued back-tax claims against retailers who ignored it ^[5][7].

Medical cannabis and VAT

Since the 1 August 2022 amendment to the BetmG, physicians can prescribe cannabis-based medicines without a special FOPH permit ^[3]. Dispensing goes through pharmacies.

Medicines authorized by Swissmedic, and magistral (compounded) preparations dispensed on prescription, are subject to the reduced VAT rate of 2.6% under Art. 25 para. 2 lit. a of the VAT Act (MWSTG, SR 641.20) and the associated ordinance listing eligible products ^[8]. Unauthorized cannabis preparations dispensed under a magistral formula also qualify for the reduced rate when supplied on prescription Strong evidence.

Reimbursement by mandatory health insurance (OKP/LAMal) is limited: as of 2024, most cannabis prescriptions are still paid out-of-pocket or reimbursed case-by-case under Art. 71a–71d KVV ^[9]. That is a coverage issue, not a tax issue, but it is the main reason patients still pay CHF 8–15 per gram equivalent Weak / limited.

Pilot-trial pricing: not a real tax regime

The pilot-trial ordinance (BetmPV) requires that cannabis sold in trials be priced comparably to the illicit market to avoid distorting participant behaviour, and that participants pay the full price themselves (Art. 15 BetmPV) ^[4]. Prices at Zurich's 'Züri Can' and Basel's 'Weed Care' trial have been reported at roughly CHF 8–12 per gram depending on THC content ^[10].

These prices include standard VAT (8.1%) but no cannabis-specific excise tax exists. The trials are explicitly research projects, not a taxation model. A recreational excise regime would require new federal legislation, which the Federal Council's post-consultation report of February 2024 indicated is still in preparation but not yet drafted into a bill ^[11] Strong evidence.

What a future recreational tax might look like

The Sub-Commission on Cannabis Regulation of the National Council's Health Commission (SGK-N) published a policy outline in 2023 recommending a state-controlled market with a THC-weighted excise tax, similar to how alcohol is taxed by ethanol content ^[12]. No rate has been legislated.

Estimates from the University of Geneva's 2022 study for the FOPH projected annual tax revenue between CHF 150 million and CHF 1 billion, depending on tax rate, price elasticity, and market size — a very wide range that reflects genuine uncertainty ^[13] Weak / limited. Anyone quoting a specific 'expected Swiss cannabis tax rate' is guessing; the Federal Council has not proposed one.

For comparison, see Cannabis Taxation in Germany and Cannabis Excise in Canada.

Disclaimer and verification

This article is informational and is not legal or tax advice. Swiss tax law is administered federally (BAZG for tobacco tax, FTA/ESTV for VAT) but interacts with cantonal enforcement. If you sell, import, or prescribe cannabis products in Switzerland, consult a Swiss lawyer or tax advisor and verify current rates directly with BAZG and ESTV.

Last verified: 15 November 2024. Key things to re-check if you're reading this later: (a) whether the Federal Council has introduced a recreational cannabis bill, (b) the current standard VAT rate, (c) whether Swissmedic has authorized additional cannabis medicines that change reimbursement, and (d) whether the pilot trials have been extended past their initial maximum duration of 10 years from authorization.

Sources

How this page was made